North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Olanzapine (CAS 132539-06-1) is a second-generation antipsychotic agent primarily synthesized via heterocyclic condensation. Its molecular formula is <strong>C<sub>17</sub>H<sub>20</sub>N<sub>4</sub>S</strong>, serving as a key API for treating schizophrenia and bipolar disorder.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Formulation of oral tablets and injectable solutions for psychiatric management.</li>
<li><strong>Research & Development:</strong> Used in clinical trials to evaluate metabolic side effects and receptor binding profiles.</li>
<li><strong>Veterinary Medicine:</strong> Off-label application for sedation in specific animal behavioral disorders.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with hypersensitivity to olanzapine or its excipients. Store in a cool, dry place below 25°C protected from light. Handle with appropriate PPE to avoid inhalation or skin contact during industrial processing.</p>